PACTR202111611256940已完成未知
Assessing the Potential of C-Reactive Protein Testing to Reduce Antibiotic Dispensation for Respiratory Tract Infections by Community Pharmacists in Nigeria: A Cluster Randomised Controlled Trial
Augustine Onwunduba0 个研究点目标入组 20 人开始时间: 2021年11月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)(—)
- 性别
- All
入选标准
- •To be included, a community pharmacy must be registered with the Pharmacists Council of Nigeria (PCN) and have at least one pharmacist, who is registered with PCN, on duty always.
排除标准
- •Prospective community pharmacies will be excluded if their managements do not consent to their participating or if their community pharmacists already use a diagnostic technique to inform antibiotic dispensation to patients with RTI symptoms.
研究者
相似试验
尚未招募
3 期
se of bed side testing of infection in reducing the duration of antibiotic therapyCTRI/2024/06/069211Seth GS Medical College and KEM Hospital
已完成
不适用
Improving Management of Patients with Acute Cough by C-reactive protein point of care testing and Communication TrainingAcute cough, respiratory tract infectionRespiratoryRespiratory tract infectionISRCTN85154857niversity Maastricht (Netherlands)400
Unknown
不适用
Evaluation of C-reactive protein in predicting conversion of laparoscopic cholecystectomyCTRI/2019/03/017965Government Medical College and Hospital68
尚未招募
Unknown
Evaluation of C-Reactive Protein (CRP) in Oral Submucous Fibrosis and Oral Squamous Cell CarcinomaCTRI/2023/09/058075Sardar patel post graduate institute of dental and medical sciences
进行中(未招募)
Unknown
Effectiveness of C-reactive protein testing for optimising antibiotic treatment in neonates and children in Zanzibareonates at risk of early onset sepsis, admitted neonates (0-28 days) with clinical signs of sepsis and admitted children (6 months to 12 years) with febrile illness or diarrheaInfections and InfestationsISRCTN25937092International Centre for Antimicrobial Resistance Solutions (ICARS)2,261
